Employing modern techniques to systematically validate the APS-MR interaction is therefore imperative, as it will not only refine our understanding of the immunomodulatory mechanism of APS but could also pioneer new pathways for developing highly targeted polysaccharide immunomodulators. Here, NR3C2 is linked to autoimmune polyendocrinopathy.